Ranbaxy Bags Atorvastatin Approval From U.S. FDA In A Nail-Biting Finish
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA grants approval for the Lipitor generic to Ranbaxy at the last moment, and Ranbaxy announces a surprise deal with Teva, but mystery remains over a final settlement with FDA.